Besides, we have also assessed the effect of IP3R blockade in combination with SSTA treatment, and synergistic suppression effects were observed on growth or GH release of GH3, GH4 or primary pituitary adenoma cells (Fig. 4d-4e, Fig. S5c-S5d). The gene discussed is H3-4; the disease is pituitary gland adenoma.